Hunter's Syndrome Caregiver Interview
Research type
Research Study
Full title
Non-interventional Study to Capture Patient and Family Experiences Through Caregiver Interview Following HIT-SHP609-094.
IRAS ID
262808
Contact name
Karen Yee
Contact email
Sponsor organisation
Shire Development LLC
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 3 months, 1 days
Research summary
Shire Pharmaceuticals through CRO RTI Health Solutions (RTI-HS) and its partner staff from AplusA a healthcare market research firm will conduct interviews with caregivers of children who have exited a phase 2/3 clinical study (HGT-HIT-094, known as AIM-IT). This is to support the clinical development program for SHP-609 for the treatment of Hunter’s syndrome.
REC name
North West - Greater Manchester South Research Ethics Committee
REC reference
19/NW/0452
Date of REC Opinion
20 Sep 2019
REC opinion
Further Information Favourable Opinion